Rapid Screening for Elemental Impurities using ICP-MS

Author(s)Fadi Abou-Shakra, Jonathan L. Sims

The authors describe a rapid, single-point calibration approach for ICP–MS analysis of raw materials used in drug product manufacturing.

The official implementation of United States Pharmacopeia (USP) <232> will require measurement of elemental impurities using inductively coupled plasma–mass spectrometry (ICP–MS). The authors describe a rapid, single-point calibration approach for ICP–MS analysis of raw materials used in drug product manufacturing.

Download Pharmaceutical Technology’s

2014 Analytical and Bioanalytical Testing eBook

.

Articles in this issue

almost 11 years ago

Article

The Challenge of Finding the Unknown

almost 11 years ago

Article

Keys to Successful Method Transfer

almost 11 years ago

Article

AQbD Adds Rigor to Method Development

almost 11 years ago

Article

Validation of a Multiplex Bead-Based Assay

almost 11 years ago

Article

Standardizing Data Management

almost 11 years ago

Article

Advances in Analytical Technology

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!